With recent approvals of semaglutide and resmetirom, the treatment landscape for metabolic dysfunction-associated steatohepatitis (MASH) has entered a new era. In this final webisode of a 4-part CME Outfitters series, expert faculty look ahead to the next wave of therapeutic innovation. This session reviews emerging strategies that build on recently approved agents, including combination approaches aimed at improving steatohepatitis, fibrosis, and cardiometabolic risk. Particular attention is given to novel incretin-based therapies, including GLP-1 receptor/glucagon receptor dual agonists, which may offer enhanced metabolic and hepatic benefits. Additionally, faculty will explore the clinical promise of fibroblast growth factor 21 (FGF-21) analogues agents with pleiotropic activity that may address liver injury while also targeting extrahepatic manifestations such as obesity, insulin resistance, and dyslipidemia. This fourth Snack in the series features experts Naim Alkhouri, MD, and Monica Tincopa, MD, MSc, who together provide practical insights and forward-looking perspectives on where MASH management is headed and what to anticipate in clinical practice.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 201 King of Prussia Rd.
Pricing
CME included with membership
| Integrative Psychiatry Certificate Program | $3,350 |
Collected from the provider’s public pages · source
Specialties served/covered
- Addiction Medicine
- Addiction Psychiatry
- Adolescent Medicine
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Critical Care Medicine
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- General & Adult Psychiatry
- General Internal Medicine
- General Operative Anesthesia
- General Otolaryngology
- General Pediatrics
- General Surgery
- Gynecologic Oncology
- Hematology
- Hospice & Palliative Medicine
- Medical Oncology
- Mood & Anxiety Disorders
- Neonatal-Perinatal Medicine
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedic Surgery
- Pain Medicine
- Physical Medicine & Rehabilitation
- Practice Management & Ethics
- Primary Care Sports Medicine
- Pulmonary Disease
- Radiation Oncology
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Urological Oncology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Rehabilitation
- Sports & Exercise Medicine
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Faculty 2
All faculty
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 0.5 credits
- MOC · Up to 0.5 points
- Commercial Support
-
ReleasedNov 13, 2025
-
Last day to claim creditJan 1, 2027 3 months left
-
Clinical Care Options, LLC (dba Decera Clinical Education) Metabolic Connections: Rethinking MASLD, MASH, and Obesity in an Evolving Management Landscape
-
Medscape, LLC The Steatotic Liver Showdown: A Game Show on MASLD/MASH
-
Premiere Education +1 Expanding the GLP-1 Landscape: Emerging Evidence and Clinical Considerations
